STAGE IV RENAL CELL CANCER AJCC V8
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer clock: does morning or afternoon treatment work better?
Disease control Not yet recruitingThis study is testing whether the time of day a standard immunotherapy treatment is given affects how well it works for people with advanced solid tumors. Researchers want to see if a patient's internal body clock influences the treatment's effectiveness. About 160 participants w…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Gut bacteria pill could supercharge cancer drugs
Disease control Not yet recruitingThis study is testing whether adding a specific probiotic (MO-03) to standard immunotherapy drugs helps people with advanced kidney cancer live longer without their cancer getting worse. Researchers believe a healthy gut might make cancer treatments work better. About 718 people …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Cold sore virus engineered to fight advanced kidney cancer in new trial
Disease control Not yet recruitingThis study is testing a two-part treatment for advanced kidney cancer that has spread and continued to grow after standard immunotherapy. The treatment combines a modified cold sore virus (RP2), injected directly into tumors to kill cancer cells and alert the immune system, with …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Gut bacteria could be key to stopping kidney Cancer's return
Disease control Not yet recruitingThis study is testing if adding a specific probiotic (CBM588) to a standard immunotherapy drug (pembrolizumab) can better prevent kidney cancer from coming back after surgery. The trial will involve 62 patients who have had surgery for high-risk kidney cancer. Researchers believe…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug aims to shrink tumors before kidney cancer surgery
Disease control Not yet recruitingThis study is testing if a new immunotherapy drug called ivonescimab can shrink tumors in patients with high-risk kidney cancer that hasn't spread. The drug is given by IV for about 3 months before the patient's standard surgery to remove the kidney. Researchers want to see if th…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC